Patient Involvement in the Transfusion Decision-Making Can Change Patient Blood Management Practice for Better or Worse.


Journal

Acta haematologica
ISSN: 1421-9662
Titre abrégé: Acta Haematol
Pays: Switzerland
ID NLM: 0141053

Informations de publication

Date de publication:
2022
Historique:
received: 21 04 2021
accepted: 05 08 2021
pubmed: 16 9 2021
medline: 9 2 2022
entrez: 15 9 2021
Statut: ppublish

Résumé

Red blood cell transfusion (RBCT) is a therapeutic procedure with important and undesirable secondary effects. Inappropriate overuse of RBCT is significant, and a significant percentage of physicians prescribe RBCT unnecessarily. Patient involvement in treatment decision-making is poor worldwide. Shared (with the patient) transfusion decision-making (TrDM) can temper a "quick finger on the trigger" of blood transfusion (BT). The objective of this study was to determine patients' preferences surrounding their involvement in the TrDM process as well as physicians' willingness to involve the patient in TrDM. The study also determined the role of patient age, gender, ethnicity, and schooling years in the TrDM process. This cross-sectional study was conducted in a variety of departments, with 123 patients over 18 years old, who received a BT for the first time. The patients completed an anonymous questionnaire which included demographic characteristics (age, gender, ethnicity, and schooling years) and 2 questions linked to potential willingness to participate in the decision to transfuse. The questionnaire response rate was 100%. The data showed that 60% of patients (especially younger patients), independent of ethnicity, preferred a passive role in TrDM and 40% preferred to share the decision. The majority of patients, especially younger patients, prefer a passive role in TrDM, possibly due to insufficient information about the need for BT and its significance. We feel that active involvement on the part of the patient can provoke a more judicious thought process about the real need of BT on the part of the physician and have a positive influence on patient blood management.

Sections du résumé

BACKGROUND
Red blood cell transfusion (RBCT) is a therapeutic procedure with important and undesirable secondary effects. Inappropriate overuse of RBCT is significant, and a significant percentage of physicians prescribe RBCT unnecessarily. Patient involvement in treatment decision-making is poor worldwide. Shared (with the patient) transfusion decision-making (TrDM) can temper a "quick finger on the trigger" of blood transfusion (BT). The objective of this study was to determine patients' preferences surrounding their involvement in the TrDM process as well as physicians' willingness to involve the patient in TrDM. The study also determined the role of patient age, gender, ethnicity, and schooling years in the TrDM process.
METHODS
This cross-sectional study was conducted in a variety of departments, with 123 patients over 18 years old, who received a BT for the first time. The patients completed an anonymous questionnaire which included demographic characteristics (age, gender, ethnicity, and schooling years) and 2 questions linked to potential willingness to participate in the decision to transfuse.
RESULTS
The questionnaire response rate was 100%. The data showed that 60% of patients (especially younger patients), independent of ethnicity, preferred a passive role in TrDM and 40% preferred to share the decision.
CONCLUSIONS
The majority of patients, especially younger patients, prefer a passive role in TrDM, possibly due to insufficient information about the need for BT and its significance. We feel that active involvement on the part of the patient can provoke a more judicious thought process about the real need of BT on the part of the physician and have a positive influence on patient blood management.

Identifiants

pubmed: 34525473
pii: 000518947
doi: 10.1159/000518947
pmc: PMC8820427
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

5-8

Informations de copyright

© 2021 The Author(s) Published by S. Karger AG, Basel.

Références

JBI Libr Syst Rev. 2012;10(58):4633-4646
pubmed: 27820528
J Gen Intern Med. 2005 Jun;20(6):531-5
pubmed: 15987329
Isr J Health Policy Res. 2017 Dec 12;6(1):49
pubmed: 29228989
N Engl J Med. 1999 Feb 11;340(6):409-17
pubmed: 9971864
Patient Educ Couns. 2015 Oct;98(10):1172-9
pubmed: 26215573
BMC Fam Pract. 2004 Mar 01;5:1
pubmed: 15053839
Implement Sci. 2006 Aug 09;1:16
pubmed: 16899124
Intern Med. 1998 Jan;37(1):18-20
pubmed: 9510394
N Engl J Med. 2014 Oct 9;371(15):1381-91
pubmed: 25270275
Eur J Public Health. 2005 Aug;15(4):355-60
pubmed: 15975955
J Am Acad Orthop Surg. 2020 May 15;28(10):419-426
pubmed: 31567900
Patient Educ Couns. 2007 Feb;65(2):189-96
pubmed: 16956742
BMJ Open. 2016 Jan 04;6(1):e010063
pubmed: 26729393
Patient Educ Couns. 2001 Apr;43(1):5-22
pubmed: 11311834
BMJ. 2000 Oct 7;321(7265):867-71
pubmed: 11021866
J Relig Health. 2020 Dec;59(6):2918-2927
pubmed: 32285248

Auteurs

Andrei Braester (A)

Galilee Medical Center, Nahariya, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Ety Shaoul (E)

Galilee Medical Center, Nahariya, Israel.

Oded Mizrachi (O)

Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Luiza Akria (L)

Galilee Medical Center, Nahariya, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Liron Shelev (L)

Galilee Medical Center, Nahariya, Israel.

Masad Barhoum (M)

Galilee Medical Center, Nahariya, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH